Gene ontology annotations for CD24 |
|
Experiment description of studies that identified CD24 in exosomes |
1 |
Experiment ID |
58 |
ISEV standards |
✘
|
EV Biophysical techniques |
✔
HSP70
|
EV Cytosolic markers |
✔
CD9
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
17700640
|
Organism |
Homo sapiens |
Experiment description |
CD24 is a marker of exosomes secreted into urine and amniotic fluid. |
Authors |
Keller S, Rupp C, Stoeck A, Runz S, Fogel M, Lugert S, Hager HD, Abdel-Bakky MS, Gutwein P, Altevogt P |
Journal name |
KI
|
Publication year |
2007 |
Sample |
Amniotic fluid |
Sample name |
Amniotic fluid |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.08-1.14 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting |
|
|
2 |
Experiment ID |
108 |
ISEV standards |
✔
EM|IEM
|
EV Biophysical techniques |
✔
HSP70
|
EV Cytosolic markers |
✔
CD81|CD9|EpCAM
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting Immunoelctron microscopy
|
PubMed ID |
21601258
|
Organism |
Homo sapiens |
Experiment description |
Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage. |
Authors |
Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marme F, Sultmann H, Altevogt P. |
Journal name |
GO
|
Publication year |
2011 |
Sample |
Malignant ascites |
Sample name |
Malignant ascites - Ovarian cancer |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (EPCAM, CD24) |
Flotation density |
1.04-1.15 g/mL
|
Molecules identified in the study |
Protein miRNA |
Methods used in the study |
Western blotting Immunoelctron microscopy |
|
|
3 |
Experiment ID |
131 |
ISEV standards |
✘
|
EV Biophysical techniques |
✔
HSP70
|
EV Cytosolic markers |
✔
EpCAM|CD9
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
19188015
|
Organism |
Homo sapiens |
Experiment description |
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes |
Authors |
Keller S, Konig AK, Marme F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. |
Journal name |
CL
|
Publication year |
2009 |
Sample |
Malignant ascites |
Sample name |
Malignant ascites - Ovarian cancer |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.08-1.14 mg/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Cytofluorographic analysis Annexin-V-FITC Western blotting FACS |
|
|
4 |
Experiment ID |
132 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✔
CD9
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
FACS
|
PubMed ID |
19188015
|
Organism |
Homo sapiens |
Experiment description |
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes |
Authors |
Keller S, Konig AK, Marme F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. |
Journal name |
CL
|
Publication year |
2009 |
Sample |
Ovarian cancer cells |
Sample name |
OVMz |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.08-1.14 mg/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Cytofluorographic analysis Annexin-V-FITC FACS |
|
|
5 |
Experiment ID |
133 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✔
CD9
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
FACS
|
PubMed ID |
19188015
|
Organism |
Homo sapiens |
Experiment description |
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes |
Authors |
Keller S, Konig AK, Marme F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. |
Journal name |
CL
|
Publication year |
2009 |
Sample |
Ovarian cancer cells |
Sample name |
SKOV3ip |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.08-1.14 mg/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Cytofluorographic analysis Annexin-V-FITC FACS |
|
|
6 |
Experiment ID |
109 |
ISEV standards |
✘
|
EV Biophysical techniques |
✔
HSP70
|
EV Cytosolic markers |
✔
CD9|MHCII|HLA-DR|CD24|EpCAM
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
21601258
|
Organism |
Homo sapiens |
Experiment description |
Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage. |
Authors |
Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marme F, Sultmann H, Altevogt P. |
Journal name |
GO
|
Publication year |
2011 |
Sample |
Pleural effusions |
Sample name |
Pleural effusions - Breast cancer |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (EPCAM) |
Flotation density |
-
|
Molecules identified in the study |
Protein miRNA |
Methods used in the study |
Western blotting |
|
|
7 |
Experiment ID |
111 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✔
CD9|CD24|EpCAM
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
21601258
|
Organism |
Homo sapiens |
Experiment description |
Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage. |
Authors |
Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marme F, Sultmann H, Altevogt P. |
Journal name |
GO
|
Publication year |
2011 |
Sample |
Serum |
Sample name |
Serum - Breast cancer |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (CD24) |
Flotation density |
-
|
Molecules identified in the study |
Protein miRNA |
Methods used in the study |
Western blotting |
|
|
8 |
Experiment ID |
57 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
HSP70
|
EV Cytosolic markers |
✔
AQP2
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting FACS
|
PubMed ID |
17700640
|
Organism |
Homo sapiens |
Experiment description |
CD24 is a marker of exosomes secreted into urine and amniotic fluid. |
Authors |
Keller S, Rupp C, Stoeck A, Runz S, Fogel M, Lugert S, Hager HD, Abdel-Bakky MS, Gutwein P, Altevogt P |
Journal name |
KI
|
Publication year |
2007 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.05-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting FACS |
|
|
Protein-protein interactions for CD24 |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
No interactions are found.
|
|
Pathways in which CD24 is involved |
|
|
|